Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections
Open Access
- 23 May 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (5) , e0010407
Abstract
Background: Lymphatic filariasis (LF) is a neglected tropical disease caused by the filarial nematodes Wuchereria bancrofti, Brugia malayi and Brugia timori. The Global Program to Eliminate LF uses mass drug administration (MDA) of anti-filarial drugs that clear microfilariae (Mf) from blood to interrupt transmission by mosquitos. New diagnostic tools are needed to assess the impact of MDA on bancroftian filariasis, because available serologic tests can remain positive after successful treatment. Methodology/Principal findings: We identified Wb-bhp-1, which encodes a W. bancrofti homologue of BmR1, the B. malayi protein used in the Brugia Rapid antibody test for brugian filariasis. Wb-bhp-1 has a single exon that encodes a 16.3 kD protein (Wb-Bhp-1) with 45% amino acid identity to BmR1. Immunohistology shows that anti-Wb-Bhp-1 antibodies primarily bind to Mf. Plasma from 124 of 224 (55%) microfilaremic individuals had IgG4 antibodies to Wb-Bhp-1 by ELISA. Serologic reactivity to Wb-Bhp-1 varied widely with samples from different regions (sensitivity range 32–92%), with 77% sensitivity for 116 samples collected from microfilaremic individuals outside of sub-Saharan Africa. This variable sensitivity highlights the importance of validating new diagnostic tests for parasitic diseases with samples from different geographical regions. Individuals with higher Mf counts were more likely to have anti-Wb-Bhp-1 antibodies. Cross-reactivity was observed with a minority of plasma samples from people with onchocerciasis (17%) or loiasis (10%). We also identified, cloned and characterized BmR1 homologues from O. volvulus and L. loa that have 41% and 38% identity to BmR1, respectively. However, antibody assays with these antigens were not sensitive for onchocerciasis or loiasis. Conclusions: Wb-Bhp-1 is a novel antigen that is useful for serologic diagnosis of bancroftian filariasis. Additional studies are needed to assess the value of this antigen for monitoring the success of filariasis elimination programs.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-021433)
- Bill and Melinda Gates Foundation (OPP1201530)
- Foundation for Barnes-Jewish Hospital (4618)
- National Institutes of Health (R01AI144161)
- National Institutes of Health (K08AI121422)
- National Institutes of Health (T32HD043010)
This publication has 50 references indexed in Scilit:
- Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug Administration (MDA)PLOS Neglected Tropical Diseases, 2012
- Identification of Wb123 as an Early and Specific Marker of Wuchereria bancrofti InfectionPLOS Neglected Tropical Diseases, 2012
- Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode Brugia malayiBMC Genomics, 2012
- A Deep Sequencing Approach to Comparatively Analyze the Transcriptome of Lifecycle Stages of the Filarial Worm, Brugia malayiPLOS Neglected Tropical Diseases, 2011
- The variant call format and VCFtoolsBioinformatics, 2011
- Stage-specific proteomic expression patterns of the human filarial parasiteBrugia malayiand its endosymbiontWolbachiaProceedings of the National Academy of Sciences, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New GuineaPLOS Neglected Tropical Diseases, 2008
- Stage- and Gender-Specific Proteomic Analysis of Brugia malayi Excretory-Secretory ProductsPLOS Neglected Tropical Diseases, 2008